Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001193522-25-000004

Director sold 5,950 shares at an average $512.13 ($3,047,201)

  • Director acquired 5,950 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SULLIVAN LOUIS W · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-22 Exercise or conversion : show line 1 in the form +3,230 $183.98 $594,255 3,230 I
2025-12-22 Exercise or conversion : show line 2 in the form +2,720 $229.81 $625,083 5,950 I
2025-12-22 Sale : show line 3 in the form −1,087 $511.22 $555,700 4,863 I
2025-12-22 Sale : show line 4 in the form −4,863 $512.34 $2,491,501 0 I
Open-market sales · 5,950 sh · avg $512.13 · $3,047,201

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-22 Exercise or conversion : show line 5 in the form Stock Options −3,230 0 I
2025-12-22 Exercise or conversion : show line 6 in the form Stock Options −2,720 1,840 I
Loading xslF345X05/primarydocument.xml…